Loading patent…
AssigneeBeiersdorf AG
InventorsUte Breitenbach, Stefan Gallinat, Ludger Kolbe, Thomas Blatt, Helga Biergiesser, Rainer Wolber, Franz Stab, Kyra Sanger
Estimating the term…
The invention relates to oligoribonucleotides, which are capable of inducing breakdown of the mRNA enzymes that break down connective tissue, and to pharmaceutical and cosmetic compositions, which are provided for topical application and which contain the oligoribonucleotides. The compositions are particularly suited for treating degenerative skin disorders.
A double-stranded oligoribonucleotide, or a physiologically compatible salt thereof which is capable of inducing the decomposition of mRNA of one or more enzymes which decompose connective tissue.
A pharmaceutical or cosmetic composition comprising a double-stranded oligoribonucleotide, or a physiologically compatible salt thereof, which is capable of inducing the decomposition of mRNA of one or more enzymes which decompose connective tissue.
A method of treating degenerative skin conditions comprising applying a double-stranded oligoribonucleotide, or a physiologically compatible salt thereof, which is capable of inducing the decomposition of mRNA of one or more enzymes which decompose connective tissue
Dependencies are inferred from the claim text.